BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 24609454)

  • 1. Feasibility, acceptability, and preliminary efficacy of a smartphone intervention for schizophrenia.
    Ben-Zeev D; Brenner CJ; Begale M; Duffecy J; Mohr DC; Mueser KT
    Schizophr Bull; 2014 Nov; 40(6):1244-53. PubMed ID: 24609454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Video-based mobile health interventions for people with schizophrenia: Bringing the "pocket therapist" to life.
    Ben-Zeev D; Brian RM; Aschbrenner KA; Jonathan G; Steingard S
    Psychiatr Rehabil J; 2018 Mar; 41(1):39-45. PubMed ID: 27295133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and usability testing of FOCUS: a smartphone system for self-management of schizophrenia.
    Ben-Zeev D; Kaiser SM; Brenner CJ; Begale M; Duffecy J; Mohr DC
    Psychiatr Rehabil J; 2013 Dec; 36(4):289-296. PubMed ID: 24015913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remote "hovering" with individuals with psychotic disorders and substance use: feasibility, engagement, and therapeutic alliance with a text-messaging mobile interventionist.
    Ben-Zeev D; Kaiser SM; Krzos I
    J Dual Diagn; 2014; 10(4):197-203. PubMed ID: 25391277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Initial Testing of an mHealth Transitions of Care Intervention for Adults with Schizophrenia-Spectrum Disorders Immediately Following a Psychiatric Hospitalization.
    Moitra E; Park HS; Gaudiano BA
    Psychiatr Q; 2021 Mar; 92(1):259-272. PubMed ID: 32613525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mobile Assessment and Treatment for Schizophrenia (MATS): a pilot trial of an interactive text-messaging intervention for medication adherence, socialization, and auditory hallucinations.
    Granholm E; Ben-Zeev D; Link PC; Bradshaw KR; Holden JL
    Schizophr Bull; 2012 May; 38(3):414-25. PubMed ID: 22080492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility and outcomes of a multi-function mobile health approach for the schizophrenia spectrum: App4Independence (A4i).
    Kidd SA; Feldcamp L; Adler A; Kaleis L; Wang W; Vichnevetski K; McKenzie K; Voineskos A
    PLoS One; 2019; 14(7):e0219491. PubMed ID: 31306439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using mobile technology to deliver a cognitive behaviour therapy-informed intervention in early psychosis (Actissist): study protocol for a randomised controlled trial.
    Bucci S; Barrowclough C; Ainsworth J; Morris R; Berry K; Machin M; Emsley R; Lewis S; Edge D; Buchan I; Haddock G
    Trials; 2015 Sep; 16():404. PubMed ID: 26357943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mHealth for Schizophrenia: Patient Engagement With a Mobile Phone Intervention Following Hospital Discharge.
    Ben-Zeev D; Scherer EA; Gottlieb JD; Rotondi AJ; Brunette MF; Achtyes ED; Mueser KT; Gingerich S; Brenner CJ; Begale M; Mohr DC; Schooler N; Marcy P; Robinson DG; Kane JM
    JMIR Ment Health; 2016 Jul; 3(3):e34. PubMed ID: 27465803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipsychotic medication versus psychological intervention versus a combination of both in adolescents with first-episode psychosis (MAPS): a multicentre, three-arm, randomised controlled pilot and feasibility study.
    Morrison AP; Pyle M; Maughan D; Johns L; Freeman D; Broome MR; Husain N; Fowler D; Hudson J; MacLennan G; Norrie J; Shiers D; Hollis C; James A;
    Lancet Psychiatry; 2020 Sep; 7(9):788-800. PubMed ID: 32649925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and Long-Term Acceptability of ExPRESS, a Mobile Phone App to Monitor Basic Symptoms and Early Signs of Psychosis Relapse.
    Eisner E; Drake RJ; Berry N; Barrowclough C; Emsley R; Machin M; Bucci S
    JMIR Mhealth Uhealth; 2019 Mar; 7(3):e11568. PubMed ID: 30924789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Acceptability and Feasibility of Using Text Messaging to Support the Delivery of Physical Health Care in those Suffering from a Psychotic Disorder: a Review of the Literature.
    Griffiths H
    Psychiatr Q; 2020 Dec; 91(4):1305-1316. PubMed ID: 32970312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding the Feasibility, Acceptability, and Efficacy of a Clinical Pharmacist-led Mobile Approach (BPTrack) to Hypertension Management: Mixed Methods Pilot Study.
    Buis LR; Roberson DN; Kadri R; Rockey NG; Plegue MA; Danak SU; Guetterman TC; Johnson MG; Choe HM; Richardson CR
    J Med Internet Res; 2020 Aug; 22(8):e19882. PubMed ID: 32780026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Smartphone-Delivered Ecological Momentary Intervention for Problem Gambling (GamblingLess: Curb Your Urge): Single-Arm Acceptability and Feasibility Trial.
    Hawker CO; Merkouris SS; Youssef GJ; Dowling NA
    J Med Internet Res; 2021 Mar; 23(3):e25786. PubMed ID: 33769294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smartphone-Enhanced Symptom Management In Psychosis: Open, Randomized Controlled Trial.
    Lewis S; Ainsworth J; Sanders C; Stockton-Powdrell C; Machin M; Whelan P; Hopkins R; He Z; Applegate E; Drake R; Bamford C; Roberts C; Wykes T
    J Med Internet Res; 2020 Aug; 22(8):e17019. PubMed ID: 32788150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Qualitative Study of Client-Clinician Text Exchanges in a Mobile Health Intervention for Individuals With Psychotic Disorders and Substance Use.
    Aschbrenner KA; Naslund JA; Gill LE; Bartels SJ; Ben-Zeev D
    J Dual Diagn; 2016; 12(1):63-71. PubMed ID: 26829356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.
    Hickie IB; Scott EM; Cross SP; Iorfino F; Davenport TA; Guastella AJ; Naismith SL; Carpenter JS; Rohleder C; Crouse JJ; Hermens DF; Koethe D; Markus Leweke F; Tickell AM; Sawrikar V; Scott J
    Med J Aust; 2019 Nov; 211 Suppl 9():S3-S46. PubMed ID: 31679171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility of using a smartphone app to assess early signs, basic symptoms and psychotic symptoms over six months: A preliminary report.
    Eisner E; Bucci S; Berry N; Emsley R; Barrowclough C; Drake RJ
    Schizophr Res; 2019 Jun; 208():105-113. PubMed ID: 30979665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment Outcomes of a Multi-Component Mobile Health Smoking Cessation Pilot Intervention for People with Schizophrenia.
    Medenblik AM; Mann AM; Beaver TA; Dedert EA; Wilson SM; Calhoun PS; Beckham JC
    J Dual Diagn; 2020 Oct; 16(4):420-428. PubMed ID: 32735514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mobile Health (mHealth) Versus Clinic-Based Group Intervention for People With Serious Mental Illness: A Randomized Controlled Trial.
    Ben-Zeev D; Brian RM; Jonathan G; Razzano L; Pashka N; Carpenter-Song E; Drake RE; Scherer EA
    Psychiatr Serv; 2018 Sep; 69(9):978-985. PubMed ID: 29793397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.